Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent's Neuroprotective Effects following Surgery.
Vincent BargnesBrian OliverEmily WangSeth GreenspanZhaosheng JinIsaac YeungSergio BergesePublished in: Pharmaceuticals (Basel, Switzerland) (2023)
Postoperative delirium (POD) represents a perioperative neurocognitive disorder that has dreaded ramifications on a patient's recovery from surgery. Dexmedetomidine displays multiple mechanisms of neuroprotection to assist in preventing POD as a part of a comprehensive anesthetic care plan. This review will cover dexmedetomidine's pharmacological overlap with the current etiological theories behind POD along with pre-clinical and clinical studies on POD prevention with dexmedetomidine. While the body of evidence surrounding the use of dexmedetomidine for POD prevention still requires further development, promising evidence exists for the use of dexmedetomidine in select dosing and circumstances to enhance recovery from surgery.
Keyphrases
- cardiac surgery
- minimally invasive
- acute kidney injury
- coronary artery bypass
- patients undergoing
- healthcare
- surgical site infection
- palliative care
- brain injury
- case report
- bipolar disorder
- acute coronary syndrome
- hip fracture
- chronic pain
- subarachnoid hemorrhage
- cerebral ischemia
- affordable care act
- health insurance